Octapharma on…
…maailman suurin yksityisomistuksessa oleva plasman jalostaja. Vuosikertomus 2023 on luettavissa täältä.
)
Meistä
Yhtiömme arvot - Ownership, Integrity, Leadership, Sustainability, Entrepreneurship - ohjaavat potilaslähtökohtaista kulttuuriamme. Haluamme sisällyttää arvot kaikkeen tekemiseen.
Diseases & Therapies
We develop and manufacture medicines for patients in three therapeutic areas: haematology, immunotherapy and critical care.
Research & Development
We carry out pre-clinical and clinical research to develop new products and ensure that they are safe to use. In 2018, we invested €87 million in our research and development work.
Our locations
We are located in 31 countries and our medicines help people in 118 countries around the world. We have seven R&D and six manufacturing sites in Europe and North America.